Grand Challenge funding will be awarded to teams moving their projects along the research spectrum toward translational impact. The goal is to accelerate impact at the bedside; therefore basic discovery phase projects will not be funded.
Integrative collaboration across disciplines is encouraged; therefore proposals submitted by co-PIs from across disciplines will be given first consideration for funding.
All funded projects will be assigned project mentors to assist in executing their milestone-driven research plans. Projects involving potential product development will also receive specialized commercialization mentorship, utilizing the ‘lean business model’ tools and techniques.
The Grand Challenge follows a two-stage process.
Stage 1 (March 2 - March 22):
Teams submit two-page proposals to be reviewed and scored by the Massey Review Committee (comprised of U-M clinicians and DOD Neurotrauma leadership).
Stage 2 (April 30 - May 20):
Based on scores assigned during Stage 1, ten teams will be invited to submit a detailed, ten-page proposal. Teams will then pitch their idea ('Shark Tank' style) to an expert panel comprised of neurointensivists, DOD representatives, entrepreneurs, and U-M clinicians and Business Development.